|
METT11D1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.414190E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.277820E-02 |
| Normal-vs-Stage2 |
4.163000E-01 |
| Normal-vs-Stage3 |
6.279400E-01 |
| Normal-vs-Stage4 |
6.864400E-01 |
| Stage1-vs-Stage2 |
3.816600E-01 |
| Stage1-vs-Stage3 |
1.795050E-01 |
| Stage1-vs-Stage4 |
4.835400E-01 |
| Stage2-vs-Stage3 |
7.932600E-01 |
| Stage2-vs-Stage4 |
9.566800E-01 |
| Stage3-vs-Stage4 |
8.912800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.055610E-02 |
| Normal-vs-AfricanAmerican |
6.978000E-02 |
| Normal-vs-Asian |
1.591410E-01 |
| Caucasian-vs-AfricanAmerican |
7.469600E-01 |
| Caucasian-vs-Asian |
8.609800E-01 |
| AfricanAmerican-vs-Asian |
7.836800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.242500E-03 |
| Normal-vs-Female |
7.813800E-01 |
| Male-vs-Female |
1.856210E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.829830E-01 |
| Normal-vs-Extreme_Weight |
2.273600E-02 |
| Normal-vs-Obese |
1.322850E-01 |
| Normal-vs-Extreme_Obese |
1.671830E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.348000E-01 |
| Normal_Weight-vs-Obese |
9.479800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.358000E-01 |
| Extreme_Weight-vs-Obese |
5.132600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.065200E-01 |
| Obese-vs-Extreme_Obese |
3.827800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.673600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.875940E-02 |
| Normal-vs-Age(61-80Yrs) |
2.250400E-02 |
| Normal-vs-Age(81-100Yrs) |
9.121000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.569600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.047600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.630170E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.618200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.554400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.751800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.557600E-04 |
| Normal-VS-Type2 PRCC |
9.445600E-01 |
| Normal-VS-KIRP CIMP |
3.264500E-02 |
| Normal-VS-Unclassified PRCC |
4.529400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.27400000017009E-07 |
| Type1 PRCC-VS-KIRP CIMP |
4.20170000000608E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
6.422400E-03 |
| Type2 PRCC-VS-KIRP CIMP |
7.694300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.987400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.527700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.230200E-01 |
| Normal-vs-N1 |
6.873600E-01 |
| Normal-vs-N2 |
7.950700E-04 |
| N0-vs-N1 |
5.622400E-01 |
| N0-vs-N2 |
4.743600E-03 |
| N1-vs-N2 |
7.898400E-03 |
|
|
